Onderzoeker
Kevin Punie
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Laboratorium Experimentele Oncologie (Afdeling)
Lid
Vanaf28 feb 2017 → Heden
Projecten
1 - 2 of 2
- Nieuwe biomerkers in de risicostratificatie, opvolging en behandeling van jonge patiënten met borstkankers en dragers van kiembaan pathogene varianten in TP53.Vanaf1 sep 2020 → 13 feb 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
- Terugval in borst- en gynaecologische kankers.Vanaf1 feb 2019 → 1 okt 2021Financiering: Privé-financiering van binnenlandse oorsprong - onbepaald
Publicaties
41 - 50 van 75
- Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants(2021)
Auteurs: Kevin Punie, Lieveke Ameye
- Body mass index and tumor infiltrating lymphocytes in triple-negative breast cancer(2021)
Auteurs: Beppe Floris, François Richard, Hans Wildiers, Kevin Punie, Ann Smeets, Ignace Vergote, Patrick Neven, Christine Desmedt
Pagina's: 146 - 153 - ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib(2021)
Auteurs: Kevin Punie
- ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer(2021)
Auteurs: Kevin Punie
- Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort(2021)
Auteurs: Hans Wildiers, Kevin Punie, Benoit Beuselinck, Paul Clement, Sileny Han, Els Van Nieuwenhuysen, Ignace Vergote, Ann Smeets, Ines Nevelsteen, Beppe Floris, et al.
Pagina's: 1041 - 1048 - Efficacy of anti‑HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer(2021)
Auteurs: Beppe Floris, Annouschka Laenen, Ignace Vergote, Hans Wildiers, Kevin Punie, Patrick Neven
Pagina's: 183 - 194 - Breast cancer screening of mutation carriers in the era of COVID-19 pandemic(2020)
Auteurs: Kevin Punie
Pagina's: 3574 - 3575 - Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial(2020)
Auteurs: Kevin Punie
Pagina's: 1090 - 1100 - Impact of solid cancer on in- hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population- based analysis(2020)
Auteurs: Hans Wildiers, Annouschka Laenen, Tatjana Geukens, Kevin Punie
- Assessment of stromal tumor infiltrating lymphocytes and immunohistochemical features in invasive micropapillary breast carcinoma with long-term outcomes(2020)
Auteurs: Kevin Punie, Annouschka Laenen, Patrick Neven, Eva Oldenburger, Ann Smeets, Ines Nevelsteen, Chantal Van Ongeval, Caroline Weltens, Christine Desmedt, Hans Wildiers, et al.
Pagina's: 985 - 998